Literature DB >> 8026565

Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity.

R M Catalioto1, A R Renzetti, M Criscuoli, J Mizrahi, A Subissi.   

Abstract

Angiotensin II and angiotensin III stimulated prostacyclin release in a time- and dose-dependent manner in both the prostatic and the non-prostatic part of the rabbit vas deferens. Also, angiotensin I enhanced the production of prostacyclin and its effect was blocked by captopril. Losartan, a type 1 (angiotensin AT1)-selective receptor antagonist, prevented the angiotensin II-induced prostacyclin release. The agonist peptide, p-aminophenylalanine angiotensin II, and the type 2 (angiotensin AT2)-selective receptor antagonist, PD123319, were found active only in the prostatic portion, suggesting heterogeneity of the receptor population. In conclusion, an angiotensin AT1 receptor mostly mediates the angiotensin-induced release of prostacyclin in the rabbit vas deferens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8026565     DOI: 10.1016/0014-2999(94)90621-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Multiple prejunctional actions of angiotensin II on noradrenergic transmission in the caudal artery of the rat.

Authors:  S L Cox; D F Story; J Ziogas
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor.

Authors:  H M Siragy; T Senbonmatsu; T Ichiki; T Inagami; R M Carey
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

3.  Involvement of nitric oxide, but not prostaglandins, in the vascular sympathoinhibitory effects of losartan in the pithed spontaneously hypertensive rat.

Authors:  C Richer; V Domergue; M P Vincent; J F Giudicelli
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.